 |
1-(2-Nitro-imidazolyl)-3-[18F]fluoro-2-propanol; 1H-1-(3-[18F]fluoro-2-hydroxypropyl0-2-nitroimidazole (18F-Misonidazole) |
|---|---|
| Trade Name | |
| Orphan Indication | Diagnostic for management of glioma |
| USA Market Approval | USA |
| USA Designation Date | 2016-04-06 00:00:00 |
| Sponsor | Advanced Imaging Projects, LLC;7947 Brookside Ct.;Lake Worth, Florida, 33467 |
